Serotonin has already been shown to affect the proliferation and metabolism of breast cancer cells by triggering two distinct signaling pathways: Jak1/STAT3 which boosts glycolysis by upregulating PKM2, and adenylyl cyclase/PKA which promotes mitochondrial biogenesis [74]. Here, STAT3 is linked to breast carcinoma.